Tempus Ai, INC 10-Q quarterly reports

Tempus AI, Inc. announced its Q2 2026 financial results, showcasing a significant increase in total net revenue driven by strong performance in both its Diagnostics and Data and applications segments.

Tempus AI, Inc. announced significant revenue increases and strategic acquisitions in its latest 10-Q filing, alongside new debt financing and ongoing legal challenges.

Tempus AI reports significant revenue growth in Q2 2025, driven by the Ambry Genetics acquisition and increased demand for its genomics and data services, despite continued net losses.

Tempus AI's Q1 2025 revenue surged, fueled by growth in both its Genomics and Data and Services segments, alongside strategic acquisitions.

Tempus AI's third quarter 2024 results show significant revenue growth driven by both genomics and data services, alongside the impact of its recent IPO.

Tempus AI's second quarter 2024 results highlight significant revenue growth and the completion of its initial public offering, alongside strategic investments in technology and research.